BMI Stock Analysis: Buy, Sell, or Hold?
BMI - Badger Meter, Inc.
$152.35
4.25 (2.87%)
β²
5d:
+1.14%
30d:
+0.1%
90d:
-15.24%
BUY
MODERATE Confidence
Analysis Updated: Mar 31, 2026 12:00 AM ET
Earnings: Apr 16, 2026
14d
Get Alerted When BMI Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
π‘ BUY OPPORTUNITY: BMI shows positive signals but monitor for confirmation. Market pricing in 2.8% decline. Moderate conviction.
π‘ BUY OPPORTUNITY: BMI shows positive signals but monitor for confirmation. Market pricing in 2.8% decline. Moderate conviction.
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$189.56
Based on 6.4% avg growth
INTRINSIC VALUE TODAY
$117.70
Trading above fair value
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 25.0x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: BMI is currently trading at $152.35, which is considered slightly high relative to its 30-day fair value range of $146.82 to $153.90. The stock's valuation (Forward PE: 27.4) is in line with its historical norms (29.8). Remarkably, the market is currently pricing in an annual earnings decline of 2.8% over the next few years. This pessimistic expectation contrasts with the company's recent 9.6% earnings growth, suggesting potential undervaluation if the company simply maintains stability.
Technical Outlook: Technically, BMI is in a strong downtrend. The price is approaching resistance at $155.74. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation.
Market Sentiment: BMI has a strong technical setup (60/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $178.00 (+16.8%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Technical Outlook: Technically, BMI is in a strong downtrend. The price is approaching resistance at $155.74. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation.
Market Sentiment: BMI has a strong technical setup (60/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $178.00 (+16.8%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Quick Decision Summary
Current Position
SLIGHTLY HIGH
Fair Price Range
$146.82 -
$153.90
Company Quality Score
62/100
(BUY)
Options IV Signal
50th percentile
(NORMAL)
Volume Confirmation
HIGH
Confidence Score
73.1%
All Signals
- NEUTRAL: Options fairly priced (IV 50th percentile)
- BULLISH: Strong technical setup (60/100)
- BULLISH: High volume confirmation
- BULLISH: Trading below Wall St target ($178.00)
Fair Price Analysis
30-Day Fair Range
$146.82 -
$153.90
Current vs Fair Value
SLIGHTLY HIGH
Expected Move (7 Days)
Β±$7.48
(4.9%)
Support & Resistance Levels
Support Level
$145.70
Resistance Level
$155.74
Current Trend
Strong Downtrend
Technical data as of
Mar 31, 2026
Fundamental Context
Forward P/E (Next Year Est.)
27.38
Wall Street Target
$178.00
(+16.8%)
Revenue Growth (YoY)
7.6%
Earnings Growth (YoY)
9.6%
Profit Margin
15.4%
Valuation Discount vs History
-2.8% cheaper
PE vs Historical
27.4 vs 29.8
FAIR
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
-2.8%
(market-implied from PE analysis)
1-Year Target
$148.08
(-3%)
2-Year Target
$143.94
(-6%)
3-Year Target
$139.91
(-8%)
3-Yr Target (if PE normalizes)
(PE: 27β30)
$152.26
(0%)
3-Year Scenarios
Using analyst projected EPS growth
Bull:
(PE: 27.4, Growth: 8.8%)
$196.00
(+29%)
Base:
(SPY PE: 22.4, Growth: 8.8%)
$159.99
(+5%)
Bear:
(PE: 19.0, Growth: 8.8%)
$135.99
(-11%)
π
Valuation based on Current Earnings
RECOVERY PLAY: Stock looks expensive now (31x PE), but valuation improves significantly next year (27x PE) as earnings recover.
Trailing PE: 30.89 | Current EPS (TTM): $4.79
Bull Case
$189.03
(+23%)
Analyst growth 16.2%, PE expands to 34.0
Base Case
$171.84
(+12%)
Market implied 16.2%, PE stable at 30.9
Bear Case
$100.60
(-35%)
Severe decline -20.0%, PE contracts to 26.3
These are projections based on PE multiples and EPS growth scenarios, not predictions. Actual results may vary significantly.
π‘
Upside Surprise Potential
If earnings stabilize (0% growth), PE could expand from 27.4 to 29.8
Stabilization Target:
$165.80
(+8.8%)
PE Expansion Potential:
+8.8%
Share & Embed Analysis
Last updated: April 01, 2026 2:10 AM ET
Data refreshes hourly during market hours. Next update: 3:10 AM
Data refreshes hourly during market hours. Next update: 3:10 AM
π₯ Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is BMI showing a specific setup today?
Insider Activity (6 Months)
2
Buys
4
Sells
Net
INSIDERS SELLING
Recent Transactions
Kimberly K Stoll
SELL
143 shares
2026-03-06
Fred J Begale
SELL
2064 shares
2026-03-04
Kimberly K Stoll
SELL
1634 shares
2026-03-03
Top Rated Scientific & Technical Instruments Stocks
Top-rated stocks in Scientific & Technical Instruments by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
COHR
Coherent Inc |
STRONG BUY
19 analysts |
$284 | 39 SELL |
|
CGNX
Cognex Corporation |
BUY
20 analysts |
$66 | 56 HOLD |
|
FTV
Fortive Corp |
BUY
20 analysts |
$63 | 56 HOLD |
|
KEYS
Keysight Technologies Inc |
STRONG BUY
13 analysts |
$299 | 58 HOLD |
|
TRMB
Trimble Inc |
STRONG BUY
12 analysts |
$91 | 55 HOLD |